What is Ligand Pharmaceuticals's gross carrying value?

Ligand Pharmaceuticals (LGND) reported gross carrying value of $208.4M in Q1 2026.

How has Ligand Pharmaceuticals's gross carrying value changed year-over-year?

Ligand Pharmaceuticals's gross carrying value increased by 3.4% year-over-year, from $201.62M to $208.4M.

What is the long-term trend for Ligand Pharmaceuticals's gross carrying value?

Over 2 years (2023 to 2025), Ligand Pharmaceuticals's gross carrying value has grown at a 77.8% compound annual growth rate (CAGR), from $70.36M to $222.38M.

Ligand Pharmaceuticals LGND Gross carrying value

Segments

By product

See full

Agenus Inc.$40.82M—

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsGross.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's gross carrying value.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's gross carrying value?: Ligand Pharmaceuticals (LGND) reported gross carrying value of $208.4M in Q1 2026.
How has Ligand Pharmaceuticals's gross carrying value changed year-over-year?: Ligand Pharmaceuticals's gross carrying value increased by 3.4% year-over-year, from $201.62M to $208.4M.
What is the long-term trend for Ligand Pharmaceuticals's gross carrying value?: Over 2 years (2023 to 2025), Ligand Pharmaceuticals's gross carrying value has grown at a 77.8% compound annual growth rate (CAGR), from $70.36M to $222.38M.